Skip to main content
. 2024 Feb 23;19:15. doi: 10.1186/s13062-024-00459-0

Fig. 4.

Fig. 4

Regulation of RARRES1 expression influenced cell migration and EMT with or without lenvatinib treatment. (A) Representative images and statistical analysis of data from transwell assays in Huh7 and SKHEP1 cells transfected with siCtrl, siRARRES1, siCtrl + lenvatinib, and siRARRES1 + lenvatinib. (B) Representative images and statistical analysis of data from transwell assays in Huh7 and SKHEP1 cells transfected with Ctrl, RARRES1, Ctrl + lenvatinib, and RARRES1 + lenvatinib. (C) Protein expression of EMT markers (E-Cadherin and Vimentin) in Huh7 and SKHEP1 cells transfected with siCtrl, siRARRES1, siCtrl + lenvatinib, and siRARRES1 + lenvatinib, or Ctrl, RARRES1, Ctrl + lenvatinib, and RARRES1 + lenvatinib. **P < 0.01, ***P < 0.001